What clinical evidence supports Lipo C with GLP-1 medications
A 2026 review in the American Journal of Sports Medicine emphasizes that despite popularity, "significant research regarding the safety and efficacy of these therapeutic methods is required before definitive recommendations can be made to patients." Only a single human case series exists for BPC-157 (for knee pain), with significant methodological flaws and no controls
The liver produces a substance called bile which is involved in a variety of processes, chiefly, breaks down fats so that the energy stored with the fat molecule can be utilized by the body
1 Our board-certified providers can screen and monitor chronic conditions, treat minor illnesses and injuries, give immunizations and annual exams, support mental health, and serve as a primary care provider in select markets
Soto-Mota et al (168) found that administering 25 ml of exogenous ketone three times a day for 4 weeks reduced the levels of glycemic control markers in patients with T2DM
In Gazda et al., a weight loss of 8.9% was obtained with all available GLP1-RA-based therapies without further specification in 33 patients, of whom an unknown proportion had T2D [6]
